April 25, 2019
Rose
Still, analysts at J.P. Morgan wrote in a note that “the modest ‘noise’ in the numbers pales in comparison to the political risk that has been discounted into the stock” so far this year. Other industry news focuses on Athenahealth and Humana.
from Kaiser Health News http://bit.ly/2IUXr0n
April 25, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
From The State Capitols: Ohio Law Would Ensure Women Know About Abortion-Reversal Treatment; Georgia Bans Shackling Of Pregnant Prisoners- Different Takes: Kavanaugh Defenders Fell Into Pro-Life Defenders’ Dangerous Trap; Does Georgia Really Want To Prosecute Women Who Miscarry?
- Viewpoints: Wiping Out Measles Again Means Focusing On Parents In Developing Countries Who Really Want Vaccines; Time To Undo Ugly Trends Leading To Early Deaths Of Black Americans
- State Highlights: Texas Planned Parenthood Funding At Risk In New Hearing; California Joins 4 Other States In Lawsuit Over Health Care Worker Dues
- Parsing Policy: Lessons On Doctors’ Rights To Refuse To Treat Patients; Be Wary Of Testing Immigrants At The Border For Kinship
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment